169 related articles for article (PubMed ID: 7542240)
1. A study of the intracellular routing of cytotoxic ribonucleases.
Wu Y; Saxena SK; Ardelt W; Gadina M; Mikulski SM; De Lorenzo C; D'Alessio G; Youle RJ
J Biol Chem; 1995 Jul; 270(29):17476-81. PubMed ID: 7542240
[TBL] [Abstract][Full Text] [Related]
2. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.
Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ
J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins.
Wu YN; Gadina M; Tao-Cheng JH; Youle RJ
J Cell Biol; 1994 May; 125(4):743-53. PubMed ID: 8188744
[TBL] [Abstract][Full Text] [Related]
4. Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.
Newton DL; Boque L; Wlodawer A; Huang CY; Rybak SM
Biochemistry; 1998 Apr; 37(15):5173-83. PubMed ID: 9548748
[TBL] [Abstract][Full Text] [Related]
5. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleases and their antitumor activity.
Matousek J
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Jul; 129(3):175-91. PubMed ID: 11461835
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of bovine seminal ribonuclease: monomer versus dimer.
Lee JE; Raines RT
Biochemistry; 2005 Dec; 44(48):15760-7. PubMed ID: 16313179
[TBL] [Abstract][Full Text] [Related]
8. RNase inhibition of human immunodeficiency virus infection of H9 cells.
Youle RJ; Wu YN; Mikulski SM; Shogen K; Hamilton RS; Newton D; D'Alessio G; Gravell M
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6012-6. PubMed ID: 8016107
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of an antitumor ribonuclease to Purkinje neurons.
Newton DL; Walbridge S; Mikulski SM; Ardelt W; Shogen K; Ackerman SJ; Rybak SM; Youle RJ
J Neurosci; 1994 Feb; 14(2):538-44. PubMed ID: 8301353
[TBL] [Abstract][Full Text] [Related]
10. Full antitumor action of recombinant seminal ribonuclease depends on the removal of its N-terminal methionine.
Adinolfi BS; Cafaro V; D'Alessio G; Di Donato A
Biochem Biophys Res Commun; 1995 Aug; 213(2):525-32. PubMed ID: 7646508
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
12. A ribonuclease inhibitor resistant dimer of human pancreatic ribonuclease displays specific antitumor activity.
Attery A; Dey P; Tripathi P; Batra JK
Int J Biol Macromol; 2018 Feb; 107(Pt B):1965-1970. PubMed ID: 29042278
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily.
Vasandani VM; Wu YN; Mikulski SM; Youle RJ; Sung C
Cancer Res; 1996 Sep; 56(18):4180-6. PubMed ID: 8797589
[TBL] [Abstract][Full Text] [Related]
14. Ribonuclease A variants with potent cytotoxic activity.
Leland PA; Schultz LW; Kim BM; Raines RT
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10407-12. PubMed ID: 9724716
[TBL] [Abstract][Full Text] [Related]
15. Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.
Rutkoski TJ; Raines RT
Curr Pharm Biotechnol; 2008 Jun; 9(3):185-9. PubMed ID: 18673284
[TBL] [Abstract][Full Text] [Related]
16. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.
Gotte G; Menegazzi M
Front Immunol; 2019; 10():2626. PubMed ID: 31849926
[TBL] [Abstract][Full Text] [Related]
17. On the track of antitumour ribonucleases.
Benito A; Ribó M; Vilanova M
Mol Biosyst; 2005 Oct; 1(4):294-302. PubMed ID: 16880994
[TBL] [Abstract][Full Text] [Related]
18. KFERQ sequence in ribonuclease A-mediated cytotoxicity.
Haigis MC; Kurten EL; Abel RL; Raines RT
J Biol Chem; 2002 Mar; 277(13):11576-81. PubMed ID: 11801605
[TBL] [Abstract][Full Text] [Related]
19. Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase.
Halicka HD; Murakami T; Papageorgio CN; Mittelman A; Mikulski SM; Shogen K; Darzynkiewicz Z
Cell Prolif; 2000 Dec; 33(6):407-17. PubMed ID: 11101012
[TBL] [Abstract][Full Text] [Related]
20. Interferon enhances the activity of the anticancer ribonuclease, onconase.
Vasandani VM; Castelli JC; Hott JS; Saxena S; Mikulski SM; Youle RJ
J Interferon Cytokine Res; 1999 May; 19(5):447-54. PubMed ID: 10386856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
